MRVI Stock: Maravai LifeSciences Holdings, Inc. Stock Price, Analysis & Insights
Get live MRVI stock price $5.13, comprehensive Maravai LifeSciences Holdings, Inc. stock analysis, charts, news, and expert forecast. Real-time MRVI stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product...
Company Information
- CEO
- Bernd Brust
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 570
Contact Information
- Website
- https://www.maravai.com
- Address
- 10770 Wateridge Circle
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.71) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Maravai LifeSciences Holdings, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Maravai LifeSciences Holdings, Inc.
- ⚠Investors should consider how Maravai LifeSciences Holdings, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.42B
P/E Ratio (TTM)
-7.23
Beta
0.71
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare MRVI with peer companies:
- Price
- $20.54
- Market cap
- 1.13B
- Price
- $8.26
- Market cap
- 539.58M
- Price
- $3.85
- Market cap
- 1.38B
- Price
- $8.78
- Market cap
- 779.00M
- Price
- $6.81
- Market cap
- 213.52M
- Price
- $2.77
- Market cap
- 499.41M
- Price
- $8.59
- Market cap
- 708.89M
- Price
- $30.99
- Market cap
- 1.40B
- Price
- $25.62
- Market cap
- 1.52B
- Price
- $8.22
- Market cap
- 1.39B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.